Treatment cost effectiveness in acute otitis media: A watch-and-wait approach versus amoxicillin | Zendy

Isabelle Gaboury | Zendy; Kathryn Coyle | Zendy; Doug Coyle | Zendy; Nicole Le Saux | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment cost effectiveness in acute otitis media: A watch-and-wait approach versus amoxicillin

Author(s) -

Isabelle Gaboury,

Kathryn Coyle,

Doug Coyle,

Nicole Le Saux

Publication year - 2010

Publication title -

paediatrics and child health

Language(s) - English

Resource type - Journals

eISSN - 1918-1485

pISSN - 1205-7088

DOI - 10.1093/pch/15.7.e14

Subject(s) - amoxicillin , medicine , acute otitis media , otitis , randomized controlled trial , cost effectiveness , pediatrics , antibiotics , surgery , biology , microbiology and biotechnology , risk analysis (engineering)

In Canada, antimicrobial treatment is the most common approach for acute otitis media. The aim of the present study was to compare the cost effectiveness of treatment with amoxicillin versus a watch-and-wait approach (WAIT) within a Canadian pediatric setting. Four hundred eighty-eight children, six months to five years of age, who participated in a randomized controlled trial were included in the study. The average medication costs per patient were higher for the amoxicillin group ($17.26) than for the WAIT group ($4.33). However, both health care ($148.44 versus $162.48) and patient costs ($23.50 versus $31.87) were greater for the WAIT group. The mean cost of treatment for the amoxicillin group was $189.20, compared with $198.68 for the WAIT group. Amoxicillin may be cost effective in treating children with acute otitis media. The potential development of antimicrobial resistance was not addressed in the present study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research